Table 3.
Direct costs (euro's) | ||||
Patients reporting costs during this period | All patients (n = 60) | |||
N (%)* | Mean costs (min-max)† | Mean costs † | Median costs (IQR) | |
Pre-diagnostic period | 23 (38) | €15 (€1–€72) | €6 | 0 (0–4) |
Diagnostic period | 36 (60) | €27 (€1–€190) | €16 | 5 (0–16) |
Follow-up visits | 49 (82) | €49 (€5–€195) | €40 | 27 (10–60) |
DOT visits | 13 (22) | €72 (€3–€417) | €16 | 0 (0–0) |
Hospitalization | 21 (35) | €301 (€2–€3960) | €105 | 0 (0–51) |
Additional costs | 39 (65) | €263 (€4–€2400) | €171 | 64 (0–251) |
TOTAL | 58 (97) | €365 (€3–€3961) | €353 | 190 (74–399) |
Time loss (days) | ||||
Patients reporting time loss during this period | All patients (n = 60) | |||
N (%)* | Mean time loss, days (min-max) | Mean time loss | Median time loss (IQR) | |
Pre-diagnostic period | 41 (68) | 0.2 (0.0–1.8) | 0.1 | 0.1 (0–0.2) |
Diagnostic period | 42 (70) | 0.3 (0.0–1.2) | 0.2 | 0.2 (0–0.4) |
Follow-up visits | 60 (100) | 0.6 (0.18–2.0) | 0.6 | 0.4 (0.3–0.8) |
DOT visits | 31 (52) | 1.3 (0.2–6.6) | 0.7 | 0.1 (0–0.7) |
Hospitalization | 28 (47) | 39.9 (1.0–180.0) | 18.6 | 0 (0–21.0) |
Other workdays lost | 39 (65) | 93.0 (21.0–600.0) | 60.5 | 31.0 (0–90.0) |
TOTAL | 60 (100) | 80.7 (0.5–637.2) | 80.7 | 59.7 (4.6–121.5) |
Definition of abbreviations: IQR = inter-quarter range; DOT = directly observed therapy
* Column percentages are given
† Costs are rounded to the nearest integer.